PEAK6 Group LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 149 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
PEAK6 Group LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$555,000
+20.9%
6,624
-11.2%
0.00%0.0%
Q1 2018$459,000
-77.9%
7,462
-79.0%
0.00%
-77.8%
Q4 2017$2,079,000
-20.8%
35,582
-21.3%
0.01%
-35.7%
Q3 2017$2,625,000
-31.6%
45,220
+42.6%
0.01%
-36.4%
Q2 2017$3,840,000
+19.6%
31,715
+11.7%
0.02%
-18.5%
Q1 2017$3,211,000
-18.4%
28,391
-21.6%
0.03%
-3.6%
Q4 2016$3,933,000
+54.0%
36,206
+133.4%
0.03%
+47.4%
Q3 2016$2,554,000
+33.6%
15,515
+15.8%
0.02%
+26.7%
Q2 2016$1,912,000
+1.6%
13,400
+6.3%
0.02%
+114.3%
Q4 2015$1,882,000
-30.8%
12,600
-23.2%
0.01%
-53.3%
Q3 2015$2,720,000
+2.4%
16,400
+49.1%
0.02%0.0%
Q2 2015$2,655,000
+224.6%
11,000
+279.3%
0.02%
+150.0%
Q1 2015$818,000
-54.5%
2,900
-61.8%
0.01%
-64.7%
Q2 2014$1,799,000
+581.4%
7,600
+850.0%
0.02%
+750.0%
Q1 2014$264,0008000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders